Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Gastroenterology Research and Practice|August 28, 2023
A Clinic-Radiomics Model for Predicting the Incidence of Persistent Organ Failure in Patients with Acute Necrotizing PancreatitisNan Liu, Yidong Wan, Yifan Tong, et al.European Journal of Radiology|April 3, 2020
High-resolution computed tomography manifestations of COVID-19 infections in patients of different agesZuhua Chen, Hongjie Fan, Jian Cai, et al.Biomaterials|June 8, 2020
Autophagy-inhibiting polymer as an effective nonviral cancer gene therapy vector with inherent apoptosis-sensitizing abilityJiafeng Wang, Xuefei Zhou, Huifang Wang, et al.Frontiers in Oncology|July 18, 2022
Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II-III Rectal CancerKe Nie, Peng Hu, Jianjun Zheng, et al.International Journal of Surgery (London, England)|February 24, 2026
Combating colorectal lung metastases via systemic therapy and thermal ablation: RAS mutation impactHongjie Fan, Tao Xu, Yulan Zeng, et al.QJM : Monthly Journal of the Association of Physicians|December 31, 2025
Efficacy and Safety of Intranasal Bencycloquidium Bromide in Nasal Symptoms of Common Cold: a Phase 3, Multicenter, Randomised, Double-blind, Placebo-controlled TrialLixiu He, Ling Yang, Haiying Yan, et al.Annals of Medicine|January 6, 2026
Management of potentially curable colorectal lung metastases with synchronous systemic therapy and percutaneous image-guided thermal ablationHongjie Fan, Bufu Tang, Xiangjun Dong, et al.Frontiers in Medicine|June 12, 2023
Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficultyZeguang Zheng, Kai Yang, Ni Liu, et al.Cancer Pathogenesis and Therapy|July 23, 2025
Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer: A randomized, double-blind, phase 3 trialYuankai Shi, Minghong Bi, Qingshan Li, et al.Translational Lung Cancer Research|September 11, 2023
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary diseaseChengzhi Zhou, Yinyin Qin, Wei Zhao, et al.Pageof 5